Divergent Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Divergent Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-38,053	Closed	-$2.4M	–	25
2020 Q3	$2.4M	Hold	38,053	–	–	0.65%	17
2020 Q2	$2.93M	Hold	38,053	–	–	0.86%	16
2020 Q1	$2.85M	Hold	38,053	–	–	1.01%	15
2019 Q4	$2.47M	Hold	38,053	–	–	0.73%	19
2019 Q3	$2.41M	Hold	38,053	–	–	0.75%	19
2019 Q2	$2.57M	Hold	38,053	–	–	0.82%	18
2019 Q1	$2.47M	Hold	38,053	–	–	0.82%	18
2018 Q4	$2.38M	Hold	38,053	–	–	0.88%	19
2018 Q3	$2.9M	Hold	38,053	–	–	1%	16
2018 Q2	$2.7M	Hold	38,053	–	–	0.97%	16
2018 Q1	$2.87M	Buy	+38,053	New	+$3.02M	1.07%	15

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Divergent Wealth Advisors's GILD Position: Q4 2020 in Review

Divergent Wealth Advisors sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 38,053 shares — an estimated $2.4M sold.

Divergent Wealth Advisors first reported a position in GILD in Q1 2018 and held it in 11 quarters. The position peaked at $2.93M in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Divergent Wealth Advisors reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
Divergent Wealth Advisors sold 38,053 Gilead Sciences shares in Q4 2020, an estimated $2.4M.
Divergent Wealth Advisors first reported a position in Gilead Sciences in Q1 2018 and held it in 11 quarters.
Divergent Wealth Advisors's Gilead Sciences position peaked at $2.93M in Q2 2020.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Divergent Wealth Advisors's 13F filing for Q4 2020, filed 22 Jan 2021.